These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

767 related items for PubMed ID: 26923521

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. CSF biomarkers and clinical progression of Parkinson disease.
    Hall S, Surova Y, Öhrfelt A, Zetterberg H, Lindqvist D, Hansson O.
    Neurology; 2015 Jan 06; 84(1):57-63. PubMed ID: 25411441
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Olfactory dysfunctions in drug-naïve Parkinson's disease with mild cognitive impairment.
    Park JW, Kwon DY, Choi JH, Park MH, Yoon HK.
    Parkinsonism Relat Disord; 2018 Jan 06; 46():69-73. PubMed ID: 29233469
    [Abstract] [Full Text] [Related]

  • 30. Longitudinal changes of CSF biomarkers in Alzheimer's disease.
    Seppälä TT, Koivisto AM, Hartikainen P, Helisalmi S, Soininen H, Herukka SK.
    J Alzheimers Dis; 2011 Jan 06; 25(4):583-94. PubMed ID: 21460434
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO, Christianson TJ, Kremers WK, Mielke MM, Machulda MM, Vassilaki M, Alhurani RE, Geda YE, Knopman DS, Petersen RC.
    JAMA Neurol; 2016 Jan 06; 73(1):93-101. PubMed ID: 26569387
    [Abstract] [Full Text] [Related]

  • 34. Odor selectivity of hyposmia and cognitive impairment in patients with Parkinson's disease.
    Mao CJ, Wang F, Chen JP, Yang YP, Chen J, Huang JY, Liu CF.
    Clin Interv Aging; 2017 Jan 06; 12():1637-1644. PubMed ID: 29070942
    [Abstract] [Full Text] [Related]

  • 35. Cross-sectional and longitudinal associations of motor fluctuations and non-motor predominance with cerebrospinal τ and Aβ as well as dementia-risk in Parkinson's disease.
    Modreanu R, Cerquera SC, Martí MJ, Ríos J, Sánchez-Gómez A, Cámara A, Fernández M, Compta Y.
    J Neurol Sci; 2017 Feb 15; 373():223-229. PubMed ID: 28131192
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cross-Sectional and Longitudinal Cognitive Correlates of FDDNP PET and CSF Amyloid-β and Tau in Parkinson's Disease1.
    Buongiorno M, Antonelli F, Compta Y, Fernandez Y, Pavia J, Lomeña F, Ríos J, Ramírez I, García JR, Soler M, Cámara A, Fernández M, Basora M, Salazar F, Sanchez-Etayo G, Valldeoriola F, Barrio JR, Marti MJ.
    J Alzheimers Dis; 2017 Feb 15; 55(3):1261-1272. PubMed ID: 27814297
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease.
    Gjerde KV, Müller B, Skeie GO, Assmus J, Alves G, Tysnes OB.
    Acta Neurol Scand; 2018 Dec 15; 138(6):508-514. PubMed ID: 30058142
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.